These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15206148)

  • 1. [Hypertension].
    Kamide K; Rakugi H
    Nihon Rinsho; 2004 Jun; 62(6):1104-7. PubMed ID: 15206148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome.
    Seravalle G; Grassi G
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):175-9. PubMed ID: 26942609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Renin-Angiotensin-Aldosterone System in Metabolic Syndrome and Obesity-related Hypertension.
    Kamide K
    Curr Hypertens Rev; 2014 Aug; ():. PubMed ID: 25115697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arterial hypertension in metabolic syndrome: pathophysiological aspects].
    Gurgenian SV; Vatinian SKh; Zelveian PA
    Ter Arkh; 2014; 86(8):128-32. PubMed ID: 25306760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and etiology of essential hypertension: role of dietary carbohydrate.
    Kopp W
    Med Hypotheses; 2005; 64(4):782-7. PubMed ID: 15694697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension, obesity, and the renin-angiotensin system: a tale of tight associations.
    Sibley S
    Minn Med; 2003 Jan; 86(1):46-8. PubMed ID: 12585560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension as part of the metabolic syndrome.
    Cheung B
    J Hum Hypertens; 2008 Dec; 22(12):871-4. PubMed ID: 18548089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.
    Zhou MS; Schulman IH; Zeng Q
    Vasc Med; 2012 Oct; 17(5):330-41. PubMed ID: 22814999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome.
    Hattori T; Murase T; Takatsu M; Nagasawa K; Matsuura N; Watanabe S; Murohara T; Nagata K
    J Am Heart Assoc; 2014 Dec; 3(6):e001312. PubMed ID: 25468654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperinsulinism/insulin resistance: cause, effect or marker of essential arterial hypertension?].
    Greco D; Sinagra D
    G Ital Cardiol; 1995 Feb; 25(2):207-16. PubMed ID: 7642026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sympathetic hyperactivity in hypertension].
    Takahashi H
    Nihon Rinsho; 2008 Aug; 66(8):1495-502. PubMed ID: 18700548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D, the renin-angiotensin system, and insulin resistance.
    Rammos G; Tseke P; Ziakka S
    Int Urol Nephrol; 2008; 40(2):419-26. PubMed ID: 18193490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.
    Grassi G
    Hypertens Res; 2006 Nov; 29(11):839-47. PubMed ID: 17345783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin resistance and arterial hypertension].
    Weidmann P; Müller-Wieland D; de Courten M; Krone W
    Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.
    Kishi T; Hirooka Y; Konno S; Sunagawa K
    J Hypertens; 2012 Aug; 30(8):1646-55. PubMed ID: 22728908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity-related hypertension: possible pathophysiological mechanisms.
    Vaněčková I; Maletínská L; Behuliak M; Nagelová V; Zicha J; Kuneš J
    J Endocrinol; 2014 Dec; 223(3):R63-78. PubMed ID: 25385879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.